Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.
Exogenous P supplementation is a common element of treatment regimens for infertility, particularly those relating to the assisted reproductive technologies.
D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D004304:Dosage Forms; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006727:Hormone Antagonists / Q000008:administration & dosage; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D008183:Luteal Phase / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D027724:Reproductive Techniques, Assisted; D009626:Terminology as Topic
D006063:Chorionic Gonadotropin; D004304:Dosage Forms; D005300:Fertility Agents, Female; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone